Albemarle (ALB) Stock Analysis & AI Equity Report

Industrial Materials USD Explore free reports

Albemarle (ALB) overview

Albemarle (ALB) stock analysis and AI equity research. For financial year 2025, Valuatum's model shows revenue of USD 5,143m and operating profit of USD -367m; the year-end share price was 141.44 USD and market capitalisation was USD 16,650m. Albemarle is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Albemarle's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueUSD 9,533mFY 2025
Share price141.44 USDFY 2025 year end
RevenueUSD 5,143mFY 2025
Operating profitUSD -367mFY 2025
Net earningsUSD -511mFY 2025
Market capitalisationUSD 16,650mFY 2025 year end

About Albemarle

Albemarle transforms essential resources into ingredients for mobility, energy, connectivity, and health markets. Its Energy Storage business develops and manufactures lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride, used in batteries, power grids, specialty glass, and other applications. The company also reports Specialties and Ketjen segments and serves customers across automotive, electronics, pharmaceuticals, agriculture, and industrial markets.

Generate the Albemarle report

Albemarle is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, usually within an hour

Sources & methodology

Financial figures are sourced from Valuatum's financial model for Albemarle and represent financial year 2025. See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on Albemarle

Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.